COX-2 overexpression has been observed in various cancers, including breast, colon, prostate, pancreatic, head and neck, skin, and lung (Crusz and Balkwill, 2015; Chatterjee et al., 2018; Desai et al., 2018). Here, PTGS2 is linked to cancer.